PTC Therapeutics, Inc. has grown revenue 7.2% a year over three years and 16% a year over five. Revenue growth, 3-year annual rate: +7.2% (Biotechnology median +17%). Revenue growth, 5-year rate: +16%, growth has slowed since the five-year average. Years of annual history on file: 15, FY2011 to FY2025, as filed.

PTCTPTC Therapeutics, Inc.

Healthcare

$64.70+7.0% 1Y

$64.70

$57.8452 weeks$86.25

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+14.2 points), but revenue shrinking (−43% year on year).

1 good, 1 to watch, 1 without data

Revenue trend−43% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +16% a year.

Margin direction+14.2 points operating

Trailing-twelve-month operating margin, 4.0% now against -10.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PTCT growing?

PTC Therapeutics, Inc. has grown revenue 7.2% a year over three years and 16% a year over five.

+7.2%

Revenue growth, 3-year annual rate · Biotechnology median +17% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +16%
Revenue growth, 5-year rate · +7.2% over three · growth has slowed since the five-year average
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed

Details›